Difference between revisions of "Bevacizumab"

From Libre Pathology
Jump to navigation Jump to search
(Created page with "'''Bevacizumab''' is an antibody that targets VEGF.<ref>{{Cite journal | last1 = Toon | first1 = CW. | last2 = Hasovits | first2 = C. | last3 = Paik | first3 = J. | last4 = F...")
(No difference)

Revision as of 15:31, 20 October 2014

Bevacizumab is an antibody that targets VEGF.[1]

References

  1. ↑ Toon, CW.; Hasovits, C.; Paik, J.; Field, M.; Chou, A.; Hugh, TJ.; Pavlakis, N.; Gill, AJ. (Jul 2014). "Skin rash, a kidney mass and a family mystery dating back to World War II.". Med J Aust 201 (1): 58-60. PMID 24999901.
Retrieved from "https://librepathology.org/w/index.php?title=Bevacizumab&oldid=34263"